T1	Participants 397 474	randomized, controlled, double-masked clinical trial of 45 eyes was conducted
T2	Participants 315 386	Department of Ophthalmology, Labbafinejad Medical Center, Tehran, Iran.
T3	Participants 497 586	38 eyes were included in the study and were divided into 2 equal groups for data analysis
